These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 417033)

  • 1. Antibody-dependent cytotoxicity against Trypanosoma rhodesiense mediated through an alternative complement pathway.
    Flemmings B; Diggs C
    Infect Immun; 1978 Mar; 19(3):928-33. PubMed ID: 417033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement in experimental Trypanosoma lewisi infection of rats.
    Jarvinen JA; Dalmasso AP
    Infect Immun; 1976 Oct; 14(4):894-902. PubMed ID: 825467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolysis by the complement of tanned erythrocytes coated with cobra venom factor: a sensitive method to detect the alternative complement pathway activity of serum.
    Okada H; Tanaka H
    J Immunol Methods; 1981; 46(1):85-95. PubMed ID: 6793665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ; Joiner KA; Frank MM
    J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer.
    Webster GF; McArthur WP
    Int Arch Allergy Appl Immunol; 1981; 66(3):304-9. PubMed ID: 6913544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
    Clas F; Loos M
    Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune serum-mediated cytotoxicity against Trypanosoma rhodesiense.
    Diggs C; Flemmings B; Dillon J; Snodgrass R; Campbell G; Esser K
    J Immunol; 1976 Apr; 116(4):1005-9. PubMed ID: 1254957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of human serum for Leishmania donovani amastigotes: antibody facilitation of alternate complement pathway-mediated killing.
    Hoover DL; Berger M; Oppenheim MH; Hockmeyer WT; Meltzer MS
    Infect Immun; 1985 Jan; 47(1):247-52. PubMed ID: 3917426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of zinc on lysis of sheep erythrocytes by guinea pig C4-deficient serum.
    Evans BD; Amiraian K
    Mol Immunol; 1987 Dec; 24(12):1345-50. PubMed ID: 3431554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.
    Juhl H; Petrella EC; Cheung NK; Bredehorst R; Vogel CW
    Immunobiology; 1997 Nov; 197(5):444-59. PubMed ID: 9413745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
    Pinckard RN; Olson MS; Giclas PC; Terry R; Boyer JT; O'Rourke RA
    J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.
    Snyderman R; Pike MC
    Infect Immun; 1975 Feb; 11(2):273-9. PubMed ID: 46215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation by measles virus cytotoxic antibodies: alternative pathway C activation by hemagglutination-inhibition antibodies but classical activation by hemolysin antibodies.
    Ehrnst AC
    J Immunol; 1977 Feb; 118(2):533-9. PubMed ID: 402419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
    Des Prez RM; Bryan CS; Hawiger J; Colley DG
    Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the selective lysis and purification of Trypanosoma cruzi.
    Nogueira N; Bianco C; Cohn Z
    J Exp Med; 1975 Jul; 142(1):224-9. PubMed ID: 807672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative complement pathway activation by C4b deposited during classical pathway activation.
    Matsushita M; Okada H
    J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.